Prevention or Delay of Type II Diabetes

2016 ADA Guideline Recommendations
Types of Diabetes Mellitus
Main Diabetes Page
Diabetes type I
Diabetes type II
Gestational Diabetes Mellitus
2016 ADA Standard of Medical Care Guideline Recommendations
Strategies for Improving Care
Classification and Diagnosis of Diabetes
Foundations of Care and Comprehensive Medical Evaluation Diabetes Self-Management, Education, and Support Nutritional Therapy
Prevention or Delay of Type II Diabetes
Glycemic Targets
Obesity Management for Treatment of Type II Diabetes
Approaches to Glycemic Treatment
Cardiovascular Disease and Risk Management Hypertension and Blood Pressure Control Lipid Management Antiplatelet Agents Coronary Heart Disease
Microvascular Complications and Foot Care Diabetic Kidney Disease Diabetic Retinopathy Diabetic Neuropathy Diabetic Footcare
Older Adults with Diabetes
Children and Adolescents with Diabetes Management of Cardiovascular Risk Factors in Children and Adolescents with Diabetes Microvascular Complications in Children and Adolescents with Diabetes
Management of Diabetes in Pregnancy
Diabetes Care in the Hospital Setting

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shivani Chaparala M.B.B.S [2]; Tarek Nafee, M.D. [3]

Regarding diabetes mellitus type 2 primary prevention, the ADA clinical practice guideline provides suggestions.

2016 ADA Standards of Medical Care in Diabetes Guidelines

"1. Patients with prediabetes should be referred to an intensive diet and physical activity behavioral counseling program adhering to the tenets of the Diabetes Prevention Program (DPP) targeting a loss of 7% of body weight and should increase their moderate-intensity physical activity (such as brisk walking) to at least 150 min/week. (Level of Evidence: A)"

"2. Follow-up counseling and maintenance programs should be offered for long- term success in preventing diabetes. (Level of Evidence: B)"

"3. Based on the cost-effectiveness of diabetes prevention, such programs should be covered by third-party payers. (Level of Evidence: B)"

"4. Metformin therapy for prevention of type 2 diabetes should be considered in those with prediabetes, especially in those with BMI >35 kg/m2, those aged <60 years, and women with prior gestational diabetes mellitus. (Level of Evidence: A)"

"5. At least annual monitoring for the development of diabetes in those with prediabetes is suggested. (Level of Evidence: E)"

"6. Screening for and treatment of modifiable risk factors for cardiovascular dis- ease is suggested. (Level of Evidence: B)"

"7. Diabetes self-management education and support programs are appropriate venues for people with prediabetes to receive education and support to de- velop and maintain behaviors that can prevent or delay the onset of diabetes. (Level of Evidence: B)"

"8. Technology-assisted tools including Internet-based social networks, distance learning, DVD-based content, and mobile applications can be useful elements of effective lifestyle modification to prevent diabetes. (Level of Evidence: B)"